Stories
Economy
Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you
The article is about sales/selling of products and consumer guidance on choosing medications. Per the editorial guidelines, this should be ignored.
{}
Economy
Private Credit's Liquidity Problem Has a Secondary Market Solution — But It's Complicated
Private credit's secondary market is growing fast, but its ability to solve the asset class's liquidity problem depends on conditions that tend to vanish under stress.
Health
WHO's First Global Forum of 800+ Collaborating Centres Signals a Shift in How Science Gets Done
The WHO just held its first-ever global forum for 800+ Collaborating Centres. What took so long, and what changes now?
Health
Dual NAD+ Strategy Reverses Muscle and Bone Aging in Mice, Raising Human Questions
A mouse study combining NMN and apigenin restored muscle and bone function in aged animals, pointing to a systems-level rethink of how NAD+ decline drives aging.
Mobility
Megawatt EV Chargers Are Here. The Cars That Need Them Are Not.
Alpitronic's new 1,000-kilowatt chargers are already installed in the U.S. — but almost no vehicle on the road today can actually use them.
Health
Life Biosciences Brings Cellular Reprogramming to Human Trials, Testing the FDA's Limits
Life Biosciences is bringing cellular reprogramming into human trials, quietly testing whether the FDA's view of aging as inevitable is finally shifting.
More Stories
Economy
China Hit Its Growth Target, But the Engine Running It Should Worry Beijing
Health
The Sterile Neutrino Is Dead. Physics Has No Replacement Ready.
Mobility
Volkswagen's Autonomous ID. Buzz Hits LA Streets in a Crowded Robotaxi Race
Health
The Alzheimer's Gene Rewires the Brain Long Before Memory Fades
Advertisementinfeed_2
Mobility
America's Budget EV Push Is Stripping Cars to the Bone — and Revealing a Deeper Problem
Slate and Dodge are stripping EVs down to crank windows and no radio — and the gap with Chinese rivals reveals a deeper structural crisis.
Health
Scientists Find a Biological Target That Could Halt Post-Surgical Delirium in Older Adults
Post-operative delirium silently accelerates dementia in older patients. A new biological target could finally give medicine a way to stop it upstream.